anonymous
Guest
anonymous
Guest
Generally, are the main competitors JnJ and Medtronic/US Surg? What is their response in accounts where this replaces their technology. What is the GPO response when this replaces a contracted item? Does the surgeon have enough clout to keep the product for patient benefit reason? What is the overall cost outcome, and do you have a story to tell about cost savings beyond just price of your product vs. Ethicon?All lies. That last post was clearly written by a manager trying to save a sinking ship. I know a ton of reps to looking to leave after the recent lovely news. All my surgeons no longer use it due to cost constraints. You can definitely do a procedure without it. The ports are way overpriced compared to standard trocars. The clinical data is BS and all smoking mirrors. Surgeons have finally figured that out. I just did another evaluation and the surgeon saw no clinical benefit. All of my surgeons had no issues going back to regular trocars.